| Application no. and date | 16176665.4 (espacenet) (Federated) (European Patent Register), 20120330 | | Patent/reg. no. and date | DK/EP 3143990, 20191127 | | Publication date | 20170322 | | Priority no. and date | US 201161470747 P, 20110401, US 201161545835 P, 20111011 | | EP pub. no. and date |
EP 3143990 20170322 | | Effective date | | | Applicant/owner | NOVARTIS AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/159979 | | Inventor | RANE, Supriya, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936-1080, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/661 (2006.01) , A61K 47/40 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61K 9/48 (2006.01) , A61P 37/06 (2006.01) | | Title | FORMULERINGER, DER OMFATTER 2-AMINO-2-[2-(4-OCTYLPHENYL)ETHYL]PROPAN-1,3-DIOL | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
